Publisert 04.10.2017

New Eurostars application for Regenics

September 18th 2017, Regenics submits its second  Eurostars R&D funding application for Vernex® in psoriasis based on EU Commision Seal of Excellence" project.

The Eurostars research program is a highly competitve option for SME funding to leading near market projects.  Regenics has Septemeber 18th 2017 submitted an application with partner RISE AB, Sweden and  Histocenter AB, Sweden as subcontractor, for development of a CE marked psoriasis device. The total project budget is 1,189,642 Euro equivalent to 17.7 million NOK. The project period will cover funding from 2018 - 2019, including option for extension to 2021.

The application is based o the recently awarded "Seal of Excellence" rating above treshold in the Horizon 2020 SME Instruments 2 funding scheme.

The Eurostars program see fierce competition for funding every year and Regenics, with partner RISE of Sweden, hope to be among the top rated projects to recieve funsing. RISE, former SP Technical Research Institue of Sweden will recieve their funding from Vinnova Sweden, while Regenics (project lead)  will be funded from the Norwegian Research Council.  


Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.